Abstract Patent foramen ovale (PFO) is a frequent finding in migraine patients. The standard technique for PFO diagnosis is actually trans-oesophageal echocardiography (TEE). It requires the injection of a contrast agent unable to pass the pulmonary filter; hence, it is possible to detect a right-to-left shunt by observing the presence of the contrast medium in the cardiac left compartment. The transcranial Doppler (TCD) device accurately measures the blood flow velocities in different cerebral arteries. It can record microembolic signals (MES) backscattered by microbubbles travelling in the cerebral circulation, and distinguish cardiac shunts from pulmonary shunts. The number of MES is correlated to the entity of the shunt. The near-infrared spectroscopy (NIRS) technique tracks the changes in the concentration of oxygenated and reduced haemoglobin in the brain tissue. PFO is revealed by an alteration of the normal vasoreactivity pattern of the subject during functional stimuli. Magnetic resonance imaging (MRI) provides, at the same time, detailed anatomical information and functional measurements. MRI dynamic perfusion sequences can be used to reliably detect PFO either by visual assessment or by signal-time curves in the pulmonary artery and in the left atrium. A good correlation between TEE and MRI grading scores has been demonstrated, even though the interindividual variability of performing the Valsalva manoeuvre could greatly reduce the sensitivity of the method. Further prospective studies are needed to confirm the PFO MRI grading and to assess the sensitivity and specificity of the method.
Introduction
In recent years, there has been growing interest in investigating the association between atrial septal abnormalities and migraine [1] . Patent foramen ovale (PFO) in particular is a frequent finding in subjects affected by severe cerebrovascular diseases [2] . Attention to PFO was initially caused by the increased number of clinical events in scuba divers with an atrial right-to-left shunt (RLS) [3] ; then by the high rate of PFO found in young people affected by cryptogenic stroke [4] .
Whether PFO constitutes a risk factor for cardiovascular or cerebrovascular pathologies is still an open clinical question, given the wide diffusion of such defects in the normal population.
The standard technique for PFO diagnosis was initially trans-thoracic echocardiography and then transoesophageal echocardiography (TEE). Both techniques require the injection of a contrast agent (an agitated mix of saline solution, blood and air) unable to pass the pulmonary filter; hence, it is possible to detect a RLS by observing the presence of the contrast medium in the cardiac left compartment. The severity of the shunt is defined on the basis of two parameters: (i) the number of microbubbles travelling across the RLS and (ii) the presence of a spontaneous shunt vs. a latent shunt, i.e., a shunt that opens only after a Valsalva manoeuvre (VM). If the presence of a spontaneous shunt is an objective datum, often the quantification of the number of bubbles passing through the shunt is not possible. In the literature, there is no agreement about the number of bubbles that are required to deem a shunt "dangerous", even though several studies considered a shunt as "large" if 20 or more microbubbles passed it [5] . Moreover, TEE is not suitable for repeated follow-up of a patient who has undergone percutaneous closure of the PFO due to its intrinsic invasivity. Critical elements of the TEE techniques are the specific positioning of the probe and the difficulty in acquiring a clear and high-resolution image due to motion artefacts and displacements induced by the execution of the VM.
The clinical interest in embolic events involves the neurologist too: embolism may cause not only acute events, but also an ischaemic suffering that could be responsible for the onset of mild cognitive impairment syndrome. This interest, together with the need for minimally invasive diagnostic techniques, led to the development of new methodologies to assess possible PFOs. On one hand, the attention was shifted to the repercussions on the brain, due to the severity of the damages it could suffer as a consequence of embolism. On the other hand, research moved towards techniques that could provide a better anatomical description of the interatrial septum and a more reliable quantification of the shunt entity.
In the following, we report supporting techniques for the assessment of PFO and provide a thorough discussion about their merits and limitations.
Transcranial Doppler
The transcranial Doppler (TCD) device is a low-cost ultrasound instrumentation that accurately measures the blood flow velocities in different cerebral arteries. It can be easily transported, is suitable for bedside monitoring and is highly tolerated by patients.
By injecting in a vein a mixed solution of saline, blood and air, the TCD can record microembolic signals (MES) backscattered by microbubbles travelling in the cerebral circulation. Today, MES originated by microbubbles can be distinguished from artefacts on the basis of an accurate power analysis of the Doppler signals; also, it is possible to distinguish cardiac shunts from pulmonary shunts and from emboli generated by deep venous thrombosis by analysing the time elapsed from the injection of the contrast agent to the arrival of the MES. Modern devices consider a valid indicator of atrial RLS the occurrence of MES within 6 s after the contrast injection. MES can be present immediately after the contrast injection (in this case the shunt is considered permanent) or they can appear only after a VM (in this case the shunt is considered latent and our clinical experience suggests VM should be repeated twice, after another contrast injection). The number of MES is correlated to the entity of the shunt. If the shunt generates few MES it is possible to count them and give an indication of "presence" when the count passes 20 MES. In some conditions, the TCD pattern is characterised by a "curtain" or "shower" appearance that precludes an accurate count of MES, but this pattern is obviously correlated to the presence of a shunt.
Qualifying elements of the TCD are: the possibility of assessing the patient in a quiet and comfortable situation; the need for a preventive instruction of the patient on the manoeuvre he/she should perform; the probe positioning, that is relatively easy and repeatable; the possibility of documenting the blood flow velocity in relation to the phases of the cardiac cycle; the possibility of monitoring MES signals not only by insonating the middle cerebral arteries, but also the vertebrobasilar district [6] .
TCD allows a standard indication for what concerns signal intensity and time, but it remains a semi-quantitative technique when used to estimate the shunt entity.
Near-infrared spectroscopy
The near-infrared spectroscopy (NIRS) technique is able to track the changes in the concentration of oxygenated and reduced haemoglobin in the brain tissue. PFO is revealed by an alteration of the normal vasoreactivity pattern of the subject during functional stimuli [7] , as reported in Figure 1 .
It is a low-cost methodology that is suitable for bedside assessment and does not require the injection of any contrast agent. Its use was stimulated by the work of Karttunen et al. [8] on ear oximetry. In fact, NIRS is the only technique that can track the ratio between O2 and CO2 in the cortical tissues with a high temporal resolution, even in response to quick and abrupt transients. NIRS remains a semi-quantitative technique, as it is not possible to measure the absolute concentration of the two kinds of haemoglobin, but only the relative concentration.
We used NIRS with a functional activation given by breath holding. A previous study revealed that NIRS is useful in evidencing the alterations of cerebral vasoreactivity of migraineurs with respect to normal subjects [9] . In the presence of a RLS, the behaviour of the NIRS patterns was not easy to detect as the physiological response given by subjects with a permanent shunt was different from that of subjects with a latent shunt. The use of NIRS revealed possible damage in the autoregulation mechanism, as it evidenced the persistence of an increased CO 2 concentration at cortical level during the compensatory vasodilation. This condition could potentially trigger a migraine attack.
Hence, despite all its limitations, NIRS could be useful also for monitoring of patients who have undergone percutaneous closure of the PFO, whose CO2 level and vasoreactivity patterns could be accurately analysed and correlated to eventual remaining symptoms.
Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) is currently considered one of the most powerful diagnostic techniques in the cardiovascular field. It is capable of providing detailed anatomical information and functional measurements simultaneously. Furthermore, it is a noninvasive technique that avoids the use of potentially harmful ionising radiation. When needed, non-nephrotoxic contrast agents may be administered to increase sensitivity and specificity of the acquired images. MRI has been proposed as an alternative method for the diagnosis of PFO, combining anatomic information with the detection of a RLS [10, 11] .
However, when a PFO is suspected, it could be very difficult to detect a measurable shunt, also during the VM. Mohor and coworkers have proposed the use of MRI dynamic perfusion sequences to reliably detect PFO either by visual assessment or by signal-time curves in the pulmonary artery and in the left atrium [12] . They have also demonstrated a good correlation between TEE and MRI grading scores, even though the interindividual variability of performing VM could greatly reduce sensitivity of the method [13] . However, MRI is the best method to noninvasively visualise atrial septal aneurysms [12] .
Further prospective studies are needed to support these findings, to confirm the PFO MRI grading and to assess the sensitivity and specificity of the method. Finally, Grebe and coworkers have demonstrated that MRI can accurately depict the anatomy of the interatrial septum after percutaneous closure of the defect, despite the presence of the occluding device [14] . 
